Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Aurobindo Pharma Limited
Press Release Apr 09 2025
Business
Apr 9 2025
3 min read

Press Release Apr 09 2025

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 09, 2025, titled "CuraTeQ Biologics completes a successful Phase 1 Pharmacokinetics study of Denosumab BP16, a proposed biosimilar to Prolia? and Xgeva?".

View Attachment